Atricure releases 2023 esg report

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management and post-operative pain management, today announced that the company has published its 2023 environmental, social and governance (esg) report highlighting the company's corporate responsibility and sustainability initiatives. “at atricure, our focus on making a positive difference for patients is at the heart.
ATRC Ratings Summary
ATRC Quant Ranking